Pangaea Oncology, S.A. (BME:PANG)

Spain flag Spain · Delayed Price · Currency is EUR
1.660
0.00 (0.00%)
Jul 10, 2025, 12:00 PM CET
12.93%
Market Cap 57.03M
Revenue (ttm) 14.35M
Net Income (ttm) -5.34M
Shares Out 34.36M
EPS (ttm) -0.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,216
Average Volume 313
Open 1.660
Previous Close 1.660
Day's Range 1.660 - 1.660
52-Week Range 1.470 - 1.800
Beta 0.11
RSI 8.40
Earnings Date May 9, 2025

About Pangaea Oncology

Pangaea Oncology, S.A., a medical services company, provides a range of services to cancer patients in Spain and the rest of European Union countries. The company offers molecular diagnostics, such as mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression; clinical trials; in vitro drug profiling, including MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing; and Dx platform, which performs companion diagnost... [Read more]

Sector Healthcare
Founded 2006
Employees 149
Stock Exchange Madrid Stock Exchange
Ticker Symbol PANG
Full Company Profile

Financial Performance

In 2023, Pangaea Oncology's revenue was 9.95 million, an increase of 49.12% compared to the previous year's 6.68 million. Losses were -4.66 million, 71.7% more than in 2022.

Financial Statements

News

There is no news available yet.